Skip to main content

Zusammenfassung

Ätiologie und Pathogenese des systemischen Lupus erythematosus (SLE) sind bis heute ungeklärt. Immunologische Faktoren scheinen dabei aber eine zentrale Rolle zu spielen, da vielfach der Nachweis von abnormen immunregulatorischen Mechanismen und einer B-Zellhyperaktivität gelungen ist, die für das Auftreten von Autoantikörpern verantwortlich sind (s. Tabelle 1). Die Charakterisierung immunregulatorischer T-Zellsubpopulationen mit monoklonalen Antikörpern hat neue Möglichkeiten der Analyse des Immunsystems eröffnet [2]. In der vorliegenden Studie weisen wir mittels T-Zellphänotypisierung nach, daß Patienten mit SLE ein klinisch wie immunologisch heterogenes Krankengut darstellen.

Herrn Prof. Dr. R. Eberl, Wien, zum 60. Geburtstag gewidmet

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Smolen JS, Steinberg AD (1981) Systemic Lupus erythematosus and pregnancy — clinical, immunological, and theoretical aspects. In: Gleicher N (ed) Reproductive immunology. Alan R. Liss Inc., New York, pp 283–302

    Google Scholar 

  2. Reinherz EL, Schlossman SF (1981) Regulation of the immune response-inducer and suppressor T lymphocyte subsets in human beings. N Engl J Med 153: 310–323

    Google Scholar 

  3. Smolen JS, Chused TM, Leiserson WM et al. (1982) Heterogeneity of immunoregulatory T cell subsets in systemic lupus erythematosus. Am J Med 72: 783–790

    PubMed  CAS  Google Scholar 

  4. Morimoto C, Reinherz EL, Schlossman SF et al. (1980) Alteration of immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Invest 66: 1171–1174

    PubMed  CAS  Google Scholar 

Literatur

  1. Arnett FC, Shulman LE (1975) Studies in familial Lupus erythematosus. Medicine 55: 313–322

    Google Scholar 

  2. Block SR, Winfield JF et al. (1975) Studies of twins with systemic Lupus erythematosus. Am J Med 59:533–552

    PubMed  CAS  Google Scholar 

  3. Reinertsen JL, Klippel JH, Johnson AK et al. (1978) B-lymphocyte alloantigens associated with systemic lupus erythematosus. N Engl J Med 299:515–518

    PubMed  CAS  Google Scholar 

  4. Gibofsky A, Winchester RJ, Patarroya M et al. (1978) Disease associations of the la-like human alloantigens; contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus. J Exp Med 148:1728–1732

    PubMed  CAS  Google Scholar 

  5. Scherak O, Smolen JS, Mayr WR (1980) HLA-DRw3 and systemic lupus erythematosus. Arthritis Rheum 23:954–957

    PubMed  CAS  Google Scholar 

  6. Celada A, Barras C, Benzonana G, Jeannet M (1980) Increased frequency of HLA-DRw3 in systemic Lupus erythematosus. Tissue Antigens 15: 283–288

    PubMed  CAS  Google Scholar 

  7. Ahearn JM, Provost TT, Dorsch CA et al. (1982) Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic Lupus erythematosus. Arthritis Rheum 25:1031–1040

    PubMed  CAS  Google Scholar 

Literatur

  1. Chattopadhyay H et al. (1979) Lack of suppressor cell activity in rheumatoid synovial lymphocytes. Scand J Immunol 10: 309

    PubMed  CAS  Google Scholar 

  2. Fox IR et al. (1982) Synovial fluid lymphocytes differ significantly from peripheral blood lymphocytes in patients with rheumatoid arthritis. J Immunol 128:1

    Google Scholar 

  3. Lydyard P et al. (1982) Immunoregulation in patients with rheumatoid arthritis. Lancet 1: 799

    Google Scholar 

  4. Burmester G et al. (1981) Ia+ T-cells in synovial fluid and tissues of patients with rheumatoid arthritis. Arthritis Rheum 24:1370

    PubMed  CAS  Google Scholar 

  5. Böyum A (1968) Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 21: 97

    Google Scholar 

  6. Gronowicz E et al. (1976) A plaque assay for all cells secreting Ig of a given type or class. Eur J Immunol 6: 588

    PubMed  CAS  Google Scholar 

Literatur

  • Abrass CK, Border WA, Hepner G (1980) Non-specificity of circulating immune complexes in patients with acute and chronic liver disease. Clin Exp Immunol 40: 292–298

    PubMed  CAS  Google Scholar 

  • Bartel JH, Maier E, Maisch B, Berg PA (1981) Nachweis von zirkulierenden Immunkomplexen mittels eines fluorometrischen Clq-solid-phase-assays (FIAX). Laboratoriumsmedizin 11: 266–269

    Google Scholar 

  • Casali P, Bossus A, Carpentier NA, Lambert PH (1977) Solid phase enzyme immunoassay or radioimmunoassay for the detection of immune complexes based on their recognition by conglutinin: conglutinin binding test. A comparative study with 125-labelled C1q binding and Raji cell RIA-tests. Clin Exp Immunol 29: 342–354

    PubMed  CAS  Google Scholar 

  • De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, Scheuer P, Schmid M, Thaler H, Uehlinger E, Wepler W (1968) A classification of chronic hepatitis. Lancet 2: 626–634

    PubMed  Google Scholar 

  • Hay FC, Nineham LJ, Roitt IM (1976) Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase Clq. Clin Exp Immunol 24: 396–400

    PubMed  CAS  Google Scholar 

  • Lambert PH (1978) A WHO collaborative study for the evaluation of eighteen methods for detecting immune complexes in serum. J Lab Clin Immunol 1:1–15

    Google Scholar 

  • Pernice W, Sodomann CP, Lüben F, Seiler FR, Sedlacek HH (1978) Antigen specific detection of HBsAg-containing immune complexes in the course of hepatitis B virus infection. Clin Exp Immunol 37: 376–380

    Google Scholar 

  • Pohl DA, Gibbons JJ, Tsai CC, Roodman ST (1980) Isolation and purification of human Clq from plasma. J Immunol Methods 36:13–27

    PubMed  CAS  Google Scholar 

  • Sayers TJ, Binder T, Berg PA (1979) Heterogeneity of anti-mitochondrial antibodies: characterization and separation of the antigen associated with the pseudolupus erythematosus syndrom. Clin Exp Immunol 37: 68–75

    PubMed  CAS  Google Scholar 

  • Sternberger LA, Hardy PH, Cuculis JJ, Meyer HG (1970) The unlabelled antibody enzyme method of immunohistochemistry. J Histochem Cytochem 18: 315–333

    PubMed  CAS  Google Scholar 

  • Thomas HC, De Villiers D, Potter B, Hodgson H, Jain S, Jewell DP, Sherlock S (1978) Immune complexes in acute and chronic liver disease. Clin Exp Immunol 31:150–157

    PubMed  CAS  Google Scholar 

  • Wands JR, Dienstag JL, Bhan AK, Feller ER, Isselbacher KJ (1978) Circulating immune complexes and complement activation in primary biliary cirrhosis. N Engl J Med 298:233–241

    PubMed  CAS  Google Scholar 

Literatur

  1. Krapf F, Renger D, Schedel I, Leiendecker K, Leyssens H, Deicher H (1982) A PEG-precipitation laser nephelometer technique for detection and characterization of circulating immune complexes in human sera. J Immunol Methods 54:107

    PubMed  CAS  Google Scholar 

  2. Zubler RH, Lange G, Lambert PH, Miescher PA (1976) Detection of immune complexes in unheated sera by a modified 125J-Clq-binding test. J Immunol 116: 232

    PubMed  CAS  Google Scholar 

  3. Branslund I, Sierstedt AG, Svehag SE, Treisner B (1981) Doubledecker rocket immune electrophoresis for direct quantitation of complement C3 split products with C3d specifities in plasma. J Immunol Methods 44: 63

    Google Scholar 

  4. Krauledat PB, Krapf FE, Baudner S, Linhart H, Kalden JR (1983) Measurement of classical and alternative complement activation may represent the humoral immune status of patients with different rheumatic diseases. Clin Rheumatol 2:103

    Google Scholar 

  5. Zubler RH, Perrin LH, Creighton WD, Lambert PH (1977) Use of polyethylene glycol (PEG) to concentrate immune complexes from serum or plasma samples. Ann Rheum Dis 36: 23

    Google Scholar 

Literatur

  • Berg PA, Brattig N (1981) Role of immune mechanisms in drug induced diseases. In: Davis M, Tredger JM (eds) Drug reactions and the liver. Williams R. Pitman Med. Ltd., London, pp 105–110

    Google Scholar 

  • Berg PA, Brattig N, Diao G-J, Schuff-Werner P (1983) Diagnose arzneimittelbedingter allergischer Nebenwir-kungen mit Hilfe des Lymphozytentransformationstests. Allergologie 6: 77–81

    Google Scholar 

  • Brattig N, Diao G-J, Berg PA (1981) (+)-cyanidanol-3 induced fever and its pathogenesis. In: Conn HO (ed) International workshop on (+)-cyanidanol-3 in diseases of the liver. R Soc Med

    Google Scholar 

  • DeSwarte RD (1980) Drug allergy. In: Patterson R (ed) Allergic diseases. Lippincott Co., Philadelphia Torento, pp 452–521

    Google Scholar 

  • Schuff-Werner P, Berg PA (1982) Klinik und Immunologie der medikamentös induzierten allergischen Leberschäden. Intern Prax 22:475–482

    Google Scholar 

Literatur

  1. Aster RH, Jandl JH (1964) Platelet sequestration in man. I. Methods. J Clin Invest 43: 843–855

    PubMed  CAS  Google Scholar 

  2. Bhakdi S, Kayser W (1981) A simple method for isolating specific antibodies to complement components. J Immunol Methods 41: 365–376

    PubMed  CAS  Google Scholar 

  3. Borne AEG Kr von dem et al. (1980) Autoimmune thrombocytopenia: detection of platelet autoantibodies with the suspension immunofluorescence test. Br J Haematol 45: 319–327

    Google Scholar 

  4. Cines DB, Schreiber AD (1979) Immune thrombocytopenia. Use of a Cooms antiglobulin test to detect IgG and C3 on platelets. N Engl J Med 300:106–111

    PubMed  CAS  Google Scholar 

  5. Hauch TW, Rosse WF (1977) Platelet-bound complement (C3) in immune thrombocytopenia. Blood 50:1129–1136

    PubMed  CAS  Google Scholar 

  6. Kayser W et al. (1981) Complement-fixing platelet autoantibodies in autoimmune thrombocytopenia. Am J Haematol 11: 213–219

    CAS  Google Scholar 

  7. Kayser W et al. (1983) Platelet-associated complement C3 in thrombocytopenic states. Br J Haematol (in press)

    Google Scholar 

  8. McMillan R (1981) Chronic idiopathic thrombocytopenic purpura. N Engl J Med 304:1135–1147

    PubMed  CAS  Google Scholar 

  9. Mueller-Eckhardt et al. (1980) The clinical significance of platelet-associated IgG: a study on 298 patients with various disorders. Br J Haematol 46: 123–131

    PubMed  CAS  Google Scholar 

  10. Myers TJ et al. (1982) Platelet-associated complement C3 in immune thrombocytopenic purpura. Blood 59: 1023–1028

    PubMed  CAS  Google Scholar 

  11. Nel JD, Stevens K (1980) A new method for the simultaneous quantitation of platelet-bound immunoglobulin (IgG) and complement (C3) employing an enzyme-linked immunosorbent assay (ELISA) procedure. Br J Haematol 44:281–290

    PubMed  CAS  Google Scholar 

  12. Veenhoven WA et al. (1980) Platelet antibodies in idiopathic thrombocytopenic purpura. Clin Exp Immunol 39:645–651

    PubMed  CAS  Google Scholar 

Literatur

  1. Berg PA, Doniach D, Poitt IM (1967) Mitochondrial antibodies in primary biliary cirrhosis. I. Localisation of the antigen to mitochondrial membranes. J Exp Med 126: 277

    PubMed  CAS  Google Scholar 

  2. Berg PA, Homberg JC, Botazzo GF, Doniach D (1981) Clinical significance of mitochondrial antibodies in relation to liver disease. Lancet 2:804

    PubMed  CAS  Google Scholar 

  3. Berg PA, Wiedmann KH, Sayers TJ, Klöppel G, Lindner H (1980) Serological classification of chronic cholestatic liver disease by the use of two different types of antimitochondrial antibodies. Lancet 2:1329–1332

    PubMed  CAS  Google Scholar 

  4. Homberg JC, Stelly N, Andreis J, Abiaf N, Saadoun F, Andre J (1982) A new anti-mitochondrial antibody (anti M6) in iproniazid induced hepatits. Clin Exp Immunol 47: 93–102

    PubMed  CAS  Google Scholar 

  5. Labro MT, Andrieu MC, Weber M, Homberg IC (1978) A new pattern of non organ specific anti-organelle antibody detected by immunofluorescence: the mitochondrial antibody number 5. Clin Exp Immunol 31: 357–366

    PubMed  CAS  Google Scholar 

  6. Lindenborn-Fotinos J, Sayers TJ, Berg PA (1982) Mitochondrial antibodies in primary biliary cirrhosis. VI. Association of the complement-fixing antigen with a component of the mitochondrial Fl-ATPase complex. Clin Exp Immunol 50: 267–274

    PubMed  CAS  Google Scholar 

  7. Maisch B, Berg PA, Kochsiek K (1980) Immunological parameter in patients with congestive cardiomyopathy. Basic Res Cardiol 75: 221–222

    PubMed  CAS  Google Scholar 

  8. Schnaitman C, Greenawalt JW (1968) Enzymatic properties of the inner and outer membranes of rat liver mitochondria. J Cell Biol 38:168

    Google Scholar 

  9. Schultheiß HP (1983) The antigenic characteristics and the significance of the adenine nucleotide translocator as a major autoantigen to antimitochondrial antibodies in myocarditis and congestive cardio myopathy. Clin Exp Immunol (submitted)

    Google Scholar 

  10. Smith AL (1976) Preparation, properties and conditions for assay of mitochondria. In: Estabrook RW, Pullmann ME (eds) Methods in enzymology X. Academic Press, New York, pp 81–86

    Google Scholar 

Literatur

  1. Auer IO (1983) Immunologische Aspekte chronisch entzündlicher Darmerkrankungen. Klin Paediatr (im Druck)

    Google Scholar 

  2. Bresnihan B, Jasin HE (1977) Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus. J Clin Invest 59:106–111

    PubMed  CAS  Google Scholar 

  3. Fineman SM, Medawar FB, Geha RS (1979) Characteristics and mechanisms of action of the ConA-activated suppressor cell in man. Cell Immunol 45:120–132

    PubMed  CAS  Google Scholar 

  4. Fiocchi C, Battisto JR, Farmer RG (1979) Gut mucosal lymphocytes in inflammatory bowel disease. Dig Dis Sci 24:705–717

    PubMed  CAS  Google Scholar 

  5. Greene WC, Fleisher ThA, Waldmann ThA (1981) Soluble suppressor supernatants elaborated by ConA-activated human mononuclear cells. J Immunol 126:1185-1191

    PubMed  CAS  Google Scholar 

  6. Hallgreen HM, Yunis EJ (1977) Suppressor lymphocytes in young and aged humans. J Immunol 118: 2004–2009

    Google Scholar 

  7. Herscowitz HB, Sakane T, Steinberg AD, Green I (1980) Heterogeneity of human suppressor cells induced by ConA as determined in simultaneous assays of immune function. J Immunol 124:1403–1410

    PubMed  CAS  Google Scholar 

  8. Hirschberg H, Thorsby E (1977) Activation of human suppressor cells in mixed lymphocyte cultures. Scand J Immunol 6:809–815

    PubMed  CAS  Google Scholar 

  9. Hodgson HJF, Wands JR, Isselbacher KJ (1978) Decreased suppressor cell activity in inflammatory bowel disease. Clin Exp Immunol 32: 451–468

    PubMed  CAS  Google Scholar 

  10. Hodgson HJF, Victorino RMM (1981) T-cell subsets, immunoregulatory cells and lymphocyte responsiveness in Crohn’s disease. In: Pena AS, Weterman IT, Booth CC, Strober W (eds) Recent advances in Crohn’s disease. Dev Gastroenterol 1:398–402

    Google Scholar 

  11. Holdstock G, Chastenay BF, Krawitt EL (1982) Functional suppressor T cell activity in Crohn’s disease and the effects of sulphasalazine. Clin Exp Immunol 48: 619–624

    PubMed  CAS  Google Scholar 

  12. Knapp W, Smolen JS, Lancer G, Berger R, Menzel EJ, Grabner G, Gangl A (1981) ConA induced suppressor cell activity in IBD. In: Pena AS, Weterman IT, Booth CC, Strober W (eds) Recent advances in Crohn’s disease. Dev Gastroenterol 1: 380–385

    Google Scholar 

  13. Maca RD, Bonnard GD, Herbermann RB (1979) The suppression of mitogen- and alloantigen stimulated peripheral blood lymphocytes by cultured human T lymphocytes. J Immunol 123:246–251

    PubMed  CAS  Google Scholar 

  14. Nussenblatt RB, Cevario SJ, Gery I (1980) Altered suppressor cell activities in uveitis. Lancet 2: 722–724

    PubMed  CAS  Google Scholar 

  15. Sakane T, Steinberg AD, Green I (1978) Studies of immune functions of patients with SLE. Arthritis Rheum 21:657–664

    PubMed  CAS  Google Scholar 

Literatur

  1. Janowitz HD (1981) Crohn’s disease — 50 Years later. N Engl J Med 304:1600–1602

    PubMed  CAS  Google Scholar 

  2. Cave DR, Mitchell DN, Brooke BN (1977) Crohn’s disease and ulcerative Colitis: a review of the evidence for transmissibility. In: Jerzy Glass GB (ed) Progress in gastroenterology. Grune and Stratton, New York San Francisco London, p 839

    Google Scholar 

  3. Strickland RG, Sachar DB (1977) The immunology of inflammatory bowel disease. In: Jerzy Glass GB (ed) Progress in gastroenterology. Grune and Stratton, New York San Francisco London, p 821

    Google Scholar 

  4. Awdeh ZL, Alper CA (1980) Inherited structural polymorphism of the fourth component of complement (C4). Proc Natl Acad Sci USA 77: 3576–3580

    PubMed  CAS  Google Scholar 

  5. Alper CA, Propp RP (1968) Genetic polymorphism of the third component of human complement (C3). J Clin Invest 47: 2181–2191

    PubMed  CAS  Google Scholar 

  6. Alper CA, Johnson AM (1969) Immunofixation electrophoresis: A technique for the study of protein polymorphism. Vox Sang 17: 445–452

    PubMed  CAS  Google Scholar 

  7. Woolf B (1955) On estimating the variation between blood groups and disease. Ann Hum Genet 251

    Google Scholar 

Literatur

  1. Bauer W, Morell A, Simona R, Baumann HR (1982) Einsatz der bronchoalveolären Lavage zur Diagnose, Aktivitätsbestimmung und Verlaufskontrolle der Sarkoidose. Schweiz Med Wochenschr 112:1835–1837

    PubMed  CAS  Google Scholar 

  2. Beaumont D, Larzul JJ, Herry JY, Sapéne M, Kernec J et al. (1981) Angiotensinconverting enzyme, gallium scanning, and bronchoalveolar lavage in evaluation of sarcoidosis. Bull Eur Physiopath Resp 17:58

    Google Scholar 

  3. Brambilla C, Chavez L, Groslambert P, Maisonneuve D, Vincent M et al. (1981) Prognosis value of bronchoalveolar lavage and ACE in sarcoidosis. Bull Eur Physiopath Resp 17: 57

    Google Scholar 

  4. Bross KJ, Pangalis GA, Staatz CG, Blume KG (1978) Demonstration of cell surface antigens and their antibodies by the peroxidase-anti-peroxidase method. Transplantation 25: 331–334

    PubMed  CAS  Google Scholar 

  5. Bross JK (1980) Nachweis von Zellmembran-Antigenen mit einer Immunperoxidase-Objektträgermethode. Habil.-Schrift, Freiburg i. Br.

    Google Scholar 

  6. Costabel U, Bross KJ, Matthys H (1982a) Lymphozytensubpopulationen in der bronchoalveolären Lavage bei Sarkoidose. Verh Dtsch Ges Inn Med 88: 422–426

    Google Scholar 

  7. Costabel U, Bross KJ, Burmeister P, Schümichen C, Löhr GW, Matthys H (1982b) Value of lung helper T-lymphocytes for the assessment of disease activity in pulmonary sarcoidosis. Eur J Respir Dis (Suppl 125) 63:128

    Google Scholar 

  8. Costabel U, Bross KJ, Matthys H, Löhr GW (1982c) Cell surface antigens of lung lymphocyte subpopulations in sarcoidosis and hypersensitivity pneumonitis. Bull Eur Physiopath Resp 18:142

    Google Scholar 

  9. Costabel U, Bross KJ, Matthys H (1983a) Pulmonary sarcoidosis: assessment of disease activity by lung lymphocyte subpopulations. Klin Wochenschr 61: 349–356

    PubMed  CAS  Google Scholar 

  10. Costabel U, Bross KJ, Fischer J, Guzman J, Matthys H (1983b) Die Bedeutung der Helfer-T-Lymphozyten in der bronchoalveolären Lavage für die Aktivitätsbeurteilung der pulmonalen Sarkoidose. Prax Kiin Pneumol 37 (im Druck)

    Google Scholar 

  11. DeRemee RA (1983) The roentgenographic staging of sarcoidosis — historic and contemporary perspectives. Chest 83:128–133

    PubMed  CAS  Google Scholar 

  12. Hirata T, Nagai S, Ohshima S, Izumi T (1982) Comparative studies of T-cell subsets in BAL fluid in patients with hypersensitivity pneumonitis and sarcoidosis. Chest 82:232

    Google Scholar 

  13. Hunninghake GW, Crystal RG (1981) Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 305: 429–434

    PubMed  CAS  Google Scholar 

  14. James DG et al. (1976) A worldwide review of sarcoidosis. Ann NY Acad Sci 278:321–334

    PubMed  CAS  Google Scholar 

  15. Lieberman J (1975) Elevation of serum angiotensin-converting enzyme level in sarcoidosis. Am J Med 59: 365–372

    PubMed  CAS  Google Scholar 

  16. Siltzbach LE (1967) Sarcoidosis: clinical features and management. Med Clin North Am 51:483–502

    PubMed  CAS  Google Scholar 

  17. Smellie H, Hoyle C (1960) The natural history of pulmonary sarcoidosis. Q J Med 29:539–558

    Google Scholar 

  18. Stanis-las-Leguern G, Choudat D, Arboux A et al. (1981) Prognostic value of serum ACE and alveolar lymphocytes in sarcoidosis. Bull Eur Physiopath Resp 17: 57

    Google Scholar 

  19. Weinberger SE, Kelman JA, Elson NA et al. (1978) Bronchoalveolar lavage in interstitial lung disease. Ann Intern Med 89:459–466

    PubMed  CAS  Google Scholar 

Literatur

  1. Bergmann L, Mitrou PS, Chedron T et al. (1982) Expression of la-like antigen in lymphatic leukaemias and non-Hodgkin lymphomas in correlation with other surface markers. Scand J Haematol 29:224–234

    PubMed  CAS  Google Scholar 

  2. Costabel U, Bross KJ, Matthys H (1982) Lymphozytensubpopulationen in der bronchoalveolären Lavage bei Sarkoidose. Verh Dtsch Ges Inn Med 88: 422ä426

    Google Scholar 

  3. Cummiskey JM, McLaughlin H, Keelan P (1976) T and B lymphocytes in sarcoidosis: a clinical correlation. Thorax 31:665–668

    PubMed  CAS  Google Scholar 

  4. Daniele RP, Rowlands DT (1976) Lymphocyte subpopulations in sarcoidosis: Correlation with disease activity and duration. Ann Intern Med 85: 593–600

    PubMed  CAS  Google Scholar 

  5. Hunninghake GW, Gadek JE, Young RC, Kawanami O, Ferrans VJ, Crystal RG (1980) Maintenance of granuloma formation in pulmonary sarcoidosis by lymphocytes within the lung. N Engl J Med 302: 594–598

    PubMed  CAS  Google Scholar 

  6. Pinkston P, Bitterman PB, Crystal RG (1983) Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med 308: 793–800

    PubMed  CAS  Google Scholar 

  7. Reynolds HY, Newball HH (1974) Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med 84: 559–573

    PubMed  CAS  Google Scholar 

  8. Rust M, Nerger K, Fooke-Achterrath M, Kronenberger H, Kühn T, Schmidts L, Tuengerthal S, Meier-Sydow J (1983) Kriterien zur Beurteilung der Aktivität einer Sarkoidose durch die bronchoalveoläre Lavage und das Angiotensin konvertierende Enzym im Serum. Prax Klin Pneumol 37 (im Druck)

    Google Scholar 

  9. Rust M, Schneider M, Kronenberger H, Nerger K, Schultze-Werninghaus G, Meier-Sydow J (1982) Bronchoalveoläre Lavage bei Sarkoidose und exogen-allergischer Alveolitis. Spezifität, Sensitivität und Aktivitätsbeurteilung. Verh Dtsch Ges Inn Med 88: 415–418

    Google Scholar 

  10. Selroos O, Nikinmaa B, Koivunen E, Riska H, Tiitinen H, Weber T (1982) Cellular immunity during follow-up of patients with sarcoidosis of varying duration. Clin Exp Immunol 50:25–33

    PubMed  CAS  Google Scholar 

Literatur

  1. Beirne GJ, Wagnild JP, Zimmerman SW, Macken PD, Burkholder PM (1977) Idiopathic crescentic glomerulonephritis. Medicine 57: 349–381

    Google Scholar 

  2. Wilson CB, Dixon FJ (1973) Antiglomerular basement membrane antibody induced glomerulonephritis. Kidney Int 3: 74–89

    PubMed  CAS  Google Scholar 

  3. Stilmant MM, Bolton WK, Sturgill BC, Schmitt GW, Couser WG (1979) Crescentic glomerulonephritis without immune deposits: Clinicopathological features. Kidney Int 15:183–195

    Google Scholar 

  4. Rees AJ, Peters DK, Compston DAS, Batchelor JR Strong association between HLA-DRw 2 and antibody-mediated Goodpasture’s syndrome. Lancet 1: 966–968

    Google Scholar 

  5. Alper CA, Awdeh ZL, Raum DD, Yunis EJ (1982) Extended major histocompatibility complex haplotypes in man: Role of alleles analogous to murine t-mutants. Clin Immunol Immunopathol 24:276–285

    PubMed  CAS  Google Scholar 

Literatur

  • Dippold WG, Lloyd KO, Li LTC, Ikeda H, Oettgen HF, Old LJ (1980) Cell surface antigens of human malignant melanoma: Definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci USA 77:6114–6118

    PubMed  CAS  Google Scholar 

  • Knuth A, Shiku H, Oettgen HF, Old LJ (1981) Specificity of melanomareactive cytotoxic T-cells before and after culture in interleukin-2. Proc Am Ass Cancer Res 72:1254

    Google Scholar 

  • Livingston PO, Shiku H, Bean MA, Pinsky CM, Oettgen HF, Old LJ (1979) Cell-Mediated cytotoxicity for cultured autologus melanoma cells. Int J Cancer 24: 34–44

    PubMed  CAS  Google Scholar 

  • Pukel CS, Lloyd KO, Travassos LR, Dippold WG, Oettgen HF, Old LJ (1982) GD3, a prominent ganglioside of human melanoma. Detection and characterization by mouse monoclonal antibody. J Exp Med 155: 1133–1147

    PubMed  CAS  Google Scholar 

  • Ueda R, Ogata S, Morrissey DM, Finstad CL, Szkudlarek J, Whitmore WF, Oettgen HF, Old LJ (1981) Cell surface antigens of human renal cancer defined by mouse monoclonal antibodies: Identification of tissue-specific kidney glycoproteins. Proc Natl Acad Sci USA 78:5122–5126

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 J. F. Bergmann Verlag, München

About this paper

Cite this paper

Smolen, J.S. et al. (1983). Klinische Immunologie. In: Schlegel, B. (eds) Verhandlungen der Deutschen Gesellschaft für innere Medizin. Verhandlungen der Deutschen Gesellschaft für innere Medizin, vol 89. J.F. Bergmann-Verlag. https://doi.org/10.1007/978-3-642-85456-9_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85456-9_23

  • Publisher Name: J.F. Bergmann-Verlag

  • Print ISBN: 978-3-8070-0335-1

  • Online ISBN: 978-3-642-85456-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics